A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder

Documenti analoghi

• Early use of long‐acting injectable antipsychotics in bipolar disorder type I: An expert consensus
  di: Eduard Vieta, et al.
  Pubblicazione: (2024)
• Distinguishing bipolar depression, bipolar mania, and major depressive disorder by gut microbial characteristics
  di: Taipeng Sun, et al.
  Pubblicazione: (2024)
• Measuring the exposome in bipolar disorder
  di: Mete Ercis, et al.
  Pubblicazione: (2024)
• Correction to “Supercharging collaboration for bipolar research—Breakthrough discoveries for thriving with bipolar disorder ( BD 2 )”
  Pubblicazione: (2024)
• Anhedonia in bipolar depression treated with ketamine
  di: Alina Wilkowska, et al.
  Pubblicazione: (2024)